WO2013048355A3 - Composition à base d'herbes pour traiter la maladie de l'hépatite c et procédé d'utilisation de cette composition à base d'herbes - Google Patents

Composition à base d'herbes pour traiter la maladie de l'hépatite c et procédé d'utilisation de cette composition à base d'herbes Download PDF

Info

Publication number
WO2013048355A3
WO2013048355A3 PCT/TR2012/000118 TR2012000118W WO2013048355A3 WO 2013048355 A3 WO2013048355 A3 WO 2013048355A3 TR 2012000118 W TR2012000118 W TR 2012000118W WO 2013048355 A3 WO2013048355 A3 WO 2013048355A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal composition
disease
treating hepatitis
usage method
herbal
Prior art date
Application number
PCT/TR2012/000118
Other languages
English (en)
Other versions
WO2013048355A2 (fr
Inventor
Vedat TATAROGLU
Original Assignee
Tataroglu Vedat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tataroglu Vedat filed Critical Tataroglu Vedat
Publication of WO2013048355A2 publication Critical patent/WO2013048355A2/fr
Publication of WO2013048355A3 publication Critical patent/WO2013048355A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Cette invention concerne une composition à base d'herbes pour traiter la maladie de l'hépatite C et le procédé d'utilisation de cette composition à base d'herbes dans le traitement de la maladie de l'hépatite C. La composition à base d'herbes pour atteindre le but de l'invention comprend des graines de chardon, de l'artichaut, de la réglisse, du curcuma, du ginseng, de la caroube, des graines d'orties, de la nigelle, du gingembre, du taraxacum et du miel.
PCT/TR2012/000118 2011-08-01 2012-08-01 Composition à base d'herbes pour traiter la maladie de l'hépatite c et procédé d'utilisation de cette composition à base d'herbes WO2013048355A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2011/07537 2011-08-01
TR2011/07537A TR201107537A2 (tr) 2011-08-01 2011-08-01 Hepatit c hastalığınınn iyileştirilmesi için bitkisel bir kompozisyon ve bu bitkisel kompozisyonun kullanım yöntemi.

Publications (2)

Publication Number Publication Date
WO2013048355A2 WO2013048355A2 (fr) 2013-04-04
WO2013048355A3 true WO2013048355A3 (fr) 2013-05-30

Family

ID=47459071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2012/000118 WO2013048355A2 (fr) 2011-08-01 2012-08-01 Composition à base d'herbes pour traiter la maladie de l'hépatite c et procédé d'utilisation de cette composition à base d'herbes

Country Status (2)

Country Link
TR (1) TR201107537A2 (fr)
WO (1) WO2013048355A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2913175A1 (fr) * 2013-05-20 2014-11-27 Indus Biotech Private Limited Procede pour gerer une fibrose hepatique, le virus de l'hepatite c et un etat associe
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US9402834B2 (en) 2014-10-21 2016-08-02 Ions Pharmaceutical S.À R.L. Human therapeutic agents
WO2017129198A1 (fr) * 2016-01-26 2017-08-03 أمل صدفي سعد على، Composition naturelle qui renforce le système immunitaire par activation des glandes pour résister aux virus, bactéries et autres microbes
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
EP3512524B1 (fr) * 2016-09-14 2021-04-07 Phoenix Biotechnology, Inc. Méthodes et compositions de traitement d'infections virales
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
EP4311540A1 (fr) * 2022-07-27 2024-01-31 Carepharm S.r.l. Composition comestible a base d'herbes contenant du dioxide de silicium et procede d'obtention

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032444A1 (fr) * 2000-10-18 2002-04-25 Wu, Bertolotti, Jy-Yuan Nouvelle composition a base d'herbes medicinales pour le traitement des maladies du foie et du vih
US20020160065A1 (en) * 2000-09-20 2002-10-31 Shalaby Said I.A. Herbal compositions and treatment methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2664935A1 (fr) 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions de traitement de l'hepatite c et procedes d'utilisation des compositions de traitement de l'hepatite c

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020160065A1 (en) * 2000-09-20 2002-10-31 Shalaby Said I.A. Herbal compositions and treatment methods
WO2002032444A1 (fr) * 2000-10-18 2002-04-25 Wu, Bertolotti, Jy-Yuan Nouvelle composition a base d'herbes medicinales pour le traitement des maladies du foie et du vih

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAVEZ M L: "TREATMENT OF HEPATITIS C WITH MILK THISTLE?", JOURNAL OF HERBAL PHARMACOTHERAPY, HAWORTH HERBAL PRESS, BINGHAMTON, US, vol. 1, no. 3, 1 January 2001 (2001-01-01), pages 79 - 90, XP009047629, ISSN: 1522-8940, DOI: 10.1300/J157V01N03_08 *
NASSIRI ASL M ET AL: "Review of pharmacological effects of glycyrrhiza sp. and its bioactive compounds", PHYTOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, vol. 22, no. 6, 1 June 2008 (2008-06-01), pages 709 - 724, XP002523763, ISSN: 0951-418X, [retrieved on 20080429], DOI: 10.1002/PTR.2362 *
SEKINE-OSAJIMA YUKO ET AL: "Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication", HEPATOLOGY RESEARCH, AMSTERDAM, NL, vol. 39, no. 1, 1 January 2009 (2009-01-01), pages 60 - 69, XP009167759, ISSN: 1386-6346, [retrieved on 20080720], DOI: 10.1111/J.1872-034X.2008.00398.X *
YU Z ET AL: "Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome", INTERNATIONAL IMMUNOPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 5, no. 3, 1 March 2005 (2005-03-01), pages 571 - 580, XP027686381, ISSN: 1567-5769, DOI: 10.1016/J.INTIMP.2004.11.004 *

Also Published As

Publication number Publication date
WO2013048355A2 (fr) 2013-04-04
TR201107537A2 (tr) 2012-01-23

Similar Documents

Publication Publication Date Title
WO2013048355A3 (fr) Composition à base d'herbes pour traiter la maladie de l'hépatite c et procédé d'utilisation de cette composition à base d'herbes
IL274469A (en) Compositions, uses and methods for the treatment of metabolic disorders and diseases
SG11201602012RA (en) Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
IL238868A0 (en) Preparations and methods for treating calluses, inflammatory disease and other disorders
ZA201506682B (en) Compositions and methods for the improved production and delivery of rna
EP2621588A4 (fr) Procédés et compositions pour le traitement de maladie en utilisant l'inhalation
HK1202416A1 (en) Compositions and methods for preventing and treating oral diseases
HK1165709A1 (zh) 治療肺部疾病的乾粉製劑和方法
HK1214179A1 (zh) 通過選擇性遞送寡核苷酸分子至特定神經元類型治療帕金森病的組合物和方法
BR112013032469A2 (pt) composição, método de sintetização de micropartículas de fumaril diquetopiperazina, método de entrega de insulina para um paciente com necessidade do mesmo e micropartícula de diquetopiperazina
ZA201102745B (en) Methods of treating pulmonary disorders with liposmal amikacin formulations
IL227773B (en) Methods and compounds for increasing sialic acid production and treating disease states associated with sialic acid
ZA201400167B (en) Treatment of respiratory disorders using trpa1 antagonists
PL2677878T3 (pl) Wstępna mieszanka substancji smakowych dla gumy do żucia, sposoby otrzymywania wstępnej mieszanki substancji smakowych oraz kompozycji gumy do żucia
PL2755498T3 (pl) Kompozycja do podawania doustnego zwierzętom i sposób jej wytwarzania
EA201590571A1 (ru) Составы на основе растений
EP2719704A4 (fr) Procédé de production de formulations injectables de produits protéiques hémodérivés et produits obtenus suivant ce procédé
EP2668955A4 (fr) Composition pour prévenir ou traiter une maladie respiratoire contenant un extrait de plante mélangé de racine de cnidium officinale et de racine de polygoni cuspidati
EP2686429A4 (fr) Compositions, procédé de préparation de ces compositions et méthode de traitement de maladies inflammatoires
EP2760908A4 (fr) Compositions de polyarylène, procédés de fabrication et articles de celles-ci
HUP1100532A2 (en) Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
SG11201402899TA (en) Methods and compositions for treating viral diseases
SG10201501606VA (en) Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders
GB201403383D0 (en) Compositions,process of preparation of said compositions and method of treating inflammatory diseases
DK2426116T3 (da) Fremgangsmåde til fremstilling af (S)-3-N-methylamino-1-(2-thienyl)-1-propanol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12808524

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 06/05/2014)

122 Ep: pct application non-entry in european phase

Ref document number: 12808524

Country of ref document: EP

Kind code of ref document: A2